Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2017. Start Trial.
Date Value
October 06, 2026 8.580
October 05, 2026 8.580
October 02, 2026 8.580
October 01, 2026 8.580
September 30, 2026 8.580
September 29, 2026 8.580
September 28, 2026 8.580
September 25, 2026 8.580
September 24, 2026 8.580
September 23, 2026 8.580
September 22, 2026 8.580
September 21, 2026 8.580
September 18, 2026 8.580
September 17, 2026 8.580
September 16, 2026 8.580
September 15, 2026 8.580
September 14, 2026 8.580
September 11, 2026 8.580
September 10, 2026 8.580
September 09, 2026 8.580
September 08, 2026 8.580
September 04, 2026 8.580
September 03, 2026 8.580
September 02, 2026 8.580
September 01, 2026 8.580
Date Value
August 31, 2026 8.580
August 28, 2026 8.580
August 27, 2026 8.580
August 26, 2026 8.580
August 25, 2026 8.578
August 24, 2026 8.576
August 21, 2026 8.572
August 20, 2026 8.569
August 19, 2026 8.570
August 18, 2026 8.568
August 17, 2026 8.569
August 14, 2026 8.562
August 13, 2026 8.565
August 12, 2026 8.556
August 11, 2026 8.567
August 10, 2026 8.561
August 07, 2026 8.558
August 06, 2026 8.562
August 05, 2026 8.538
August 04, 2026 8.532
August 03, 2026 8.538
July 31, 2026 8.536
July 30, 2026 8.579
July 29, 2026 8.529
July 28, 2026 8.542

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
argenx SE --
ACADIA Pharmaceuticals, Inc. 2.591
Alnylam Pharmaceuticals, Inc. 22.53
Savara, Inc. 7.206
Vericel Corp. 5.584

Price to Book Value Related Metrics

Price 76.99
Earnings Yield -6.66%
Market Cap 1.577B